Comparison of antiangina therapies in patients with coronary heart disease in China: study protocol for a multicentre, retrospective, hospital system-based study

INTRODUCTION: China has the largest number of patients with coronary heart disease (CHD) in the world. Numerous pharmacological strategies are available for CHD in routine clinical practice. CHD-induced angina pectoris affects patients’ quality of life and is a key predictor of prognosis. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ping, Chen, Juan, Ke, Zheng, Han, Jing, Shen, Lan, Zhou, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925860/
https://www.ncbi.nlm.nih.gov/pubmed/33550222
http://dx.doi.org/10.1136/bmjopen-2020-036954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925860/
https://www.ncbi.nlm.nih.gov/pubmed/33550222
http://dx.doi.org/10.1136/bmjopen-2020-036954

Ejemplares similares